Related Experiment Videos
Ocular bacterial infections: current and future treatment options
Regis P Kowalski1, Deepinder K Dhaliwal
1University of Pittsburgh, Associate Clinical Director of the Charles T Campbell Ophthalmic Microbiology Laboratory, Pittsburgh, PA 15213, USA. kowalskirp@upmc.edu
Expert Review of Anti-Infective Therapy
|March 11, 2005
Summary
This review covers bacterial eye infections, focusing on pathogens, antibiotics, and rising resistance to common treatments like fluoroquinolones. While new antibiotics aren't immediately needed, monitoring resistance is crucial for effective ocular infection management.
Area of Science:
- Ophthalmology
- Microbiology
- Pharmacology
Background:
- Bacterial ocular infections are a common clinical challenge.
- Topical antibiotics are the primary treatment modality for ophthalmic infections.
- Current susceptibility testing relies on systemic standards due to a lack of specific ocular standards.
Purpose of the Study:
- To review common bacterial ocular infections.
- To examine bacterial pathogens, antibiotic options, and antimicrobial resistance trends.
- To discuss current and future treatment strategies for ocular bacterial infections.
Main Methods:
- Literature review of common ocular bacterial infections.
- Analysis of antibiotic usage and resistance patterns in ophthalmology.
- Examination of current and emerging treatment options.
Main Results:
- A range of established and novel antibiotics are available for treating bacterial eye infections.
- Increasing resistance to widely used fluoroquinolone antibiotics is a growing concern.
- No immediate need for entirely new ophthalmic antibiotics has been identified.
Conclusions:
- Effective management of bacterial ocular infections requires careful consideration of antibiotic resistance.
- Continued surveillance of resistance trends, particularly for fluoroquinolones, is essential.
- Ophthalmologists have a robust selection of treatments, but vigilance against emerging resistance is paramount.